Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins

[1]  H. Turkez,et al.  Protective effects of cyclosativene on H2O2-induced injury in cultured rat primary cerebral cortex cells , 2015, Cytotechnology.

[2]  A. Huizink,et al.  Prenatal cannabis exposure and infant outcomes: Overview of studies , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  K. Zou,et al.  Protective effect of tomatine against hydrogen peroxide‐induced neurotoxicity in neuroblastoma (SH‐SY5Y) cells , 2014, The Journal of pharmacy and pharmacology.

[4]  G. Esquiva,et al.  Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration. , 2014, Experimental eye research.

[5]  M. Elsohly,et al.  Synthetic cannabinoids: analysis and metabolites. , 2014, Life sciences.

[6]  N. Schröder,et al.  Cannabidiol Normalizes Caspase 3, Synaptophysin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection , 2014, Molecular Neurobiology.

[7]  B. Porter,et al.  Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy , 2013, Epilepsy & Behavior.

[8]  A. D. da Silva,et al.  Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants , 2013, Molecules.

[9]  I. Galve-Roperh,et al.  Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. , 2013, Progress in lipid research.

[10]  Dick F. Swaab,et al.  Phenotypic Characterization of Retinoic Acid Differentiated SH-SY5Y Cells by Transcriptional Profiling , 2013, PloS one.

[11]  J. Martínez-Orgado,et al.  Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? , 2013, British journal of clinical pharmacology.

[12]  H. Lim,et al.  Uncovering a role for endocannabinoid signaling in autophagy in preimplantation mouse embryos. , 2013, Molecular human reproduction.

[13]  R. Murray,et al.  Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment , 2013, Journal of psychopharmacology.

[14]  R. Pertwee.  Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[15]  F. Guillemot,et al.  The CB1 Cannabinoid Receptor Drives Corticospinal Motor Neuron Differentiation through the Ctip2/Satb2 Transcriptional Regulation Axis , 2012, The Journal of Neuroscience.

[16]  V. Cinquina,et al.  Cannabidiol administration after hypoxia–ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function , 2012, Neuropharmacology.

[17]  J. Zajicek,et al.  Δ9‐tetrahydrocannabinol (Δ9‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease , 2012, Neuropathology and applied neurobiology.

[18]  M. Beal,et al.  Mitochondrial Dysfunction in Neurodegenerative Diseases , 2012, Journal of Pharmacology and Experimental Therapeutics.

[19]  M. Pistis,et al.  Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids , 2012, Molecular Neurobiology.

[20]  R. Pertwee,et al.  Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors. , 2012, ACS chemical neuroscience.

[21]  S. Potvin,et al.  Cannabidiol in Humans—The Quest for Therapeutic Targets , 2012, Pharmaceuticals.

[22]  F. Markowetz,et al.  RedeR: R/Bioconductor package for representing modular structures, nested networks and multiple levels of hierarchical associations , 2012, Genome Biology.

[23]  N. Schröder,et al.  Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders , 2012, Psychopharmacology.

[24]  F. Klamt,et al.  Evaluation of the Neurotoxic/Neuroprotective Role of Organoselenides Using Differentiated Human Neuroblastoma SH-SY5Y Cell Line Challenged with 6-Hydroxydopamine , 2012, Neurotoxicity Research.

[25]  J. Martínez-Orgado,et al.  Cannabidiol Reduces Brain Damage and Improves Functional Recovery After Acute Hypoxia-Ischemia in Newborn Pigs , 2011, Pediatric Research.

[26]  J. Crippa,et al.  Safety and side effects of cannabidiol, a Cannabis sativa constituent. , 2011, Current drug safety.

[27]  M. Bossong,et al.  Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia , 2010, Progress in Neurobiology.

[28]  J. Quevedo,et al.  Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture , 2010, Brain Research.

[29]  K. Fabel,et al.  Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis , 2010, Cell Communication and Signaling.

[30]  Fabio Klamt,et al.  Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies , 2010, Brain Research.

[31]  M. Jimenez-Del-Rio,et al.  Protective Effects of the Synthetic Cannabinoids CP55,940 and JWH-015 on Rat Brain Mitochondria upon Paraquat Exposure , 2010, Neurochemical Research.

[32]  A. Howlett,et al.  CB(1) cannabinoid receptors and their associated proteins. , 2010, Current medicinal chemistry.

[33]  J. Hallak,et al.  [Therapeutical use of the cannabinoids in psychiatry]. , 2010, Revista brasileira de psiquiatria.

[34]  S. Rehen,et al.  Cannabinoids modulate cell survival in embryoid bodies , 2010, Cell biology international.

[35]  José Alexandre de Souza Crippa,et al.  Uso terapêutico dos canabinoides em psiquiatria , 2010 .

[36]  R. Capasso,et al.  Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. , 2009, Trends in pharmacological sciences.

[37]  J. Moreira,et al.  Optimization and validation of an alternative method to evaluate total reactive antioxidant potential. , 2009, Analytical biochemistry.

[38]  J. Martínez-Orgado,et al.  Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets , 2008, Pediatric Research.

[39]  A. Schapira.  Mitochondrial Dysfunction in Neurodegenerative Diseases , 2008, Neurochemical Research.

[40]  R. Ozawa,et al.  Identification and Classification of Genes Regulated by Phosphatidylinositol 3-kinase-and Trkb-mediated Signalling Pathways during Neuronal Differentiation in Two Subtypes of the Human Neuroblastoma Cell Line Sh-sy5y , 2022 .

[41]  A. Zuardi.  Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. , 2008, Revista brasileira de psiquiatria.

[42]  M. Schrader,et al.  6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells. , 2008, Free radical biology & medicine.

[43]  D. Weiss,et al.  Application of in vitro neurotoxicity testing for regulatory purposes: Symposium III summary and research needs. , 2008, Neurotoxicology.

[44]  A. Graham,et al.  The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation , 2008, Molecular and Cellular Neuroscience.

[45]  William R Mundy,et al.  Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. , 2008, Neurotoxicology.

[46]  R. Mechoulam,et al.  Cannabidiol reduced the striatal atrophy caused 3‐nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors , 2007, The European journal of neuroscience.

[47]  R. Mechoulam,et al.  Cannabidiol – Recent Advances , 2007, Chemistry & biodiversity.

[48]  A. Makriyannis,et al.  Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells , 2007, PloS one.

[49]  K. Mackie,et al.  The emerging functions of endocannabinoid signaling during CNS development. , 2007, Trends in pharmacological sciences.

[50]  I. Galve-Roperh,et al.  Non‐psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  Mohini Ranganathan,et al.  The acute effects of cannabinoids on memory in humans: a review , 2006, Psychopharmacology.

[52]  A. Storch,et al.  Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant α-synucleins related to Parkinson's disease , 2006, Neurochemistry International.

[53]  R. Nelson,et al.  Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. , 2005, Diabetes.

[54]  R. Hampson,et al.  Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores , 2005, Neuropharmacology.

[55]  R. Mechoulam,et al.  Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease , 2005, Neurobiology of Disease.

[56]  A. Graham,et al.  Cannabinoid receptor, CB1, expression follows neuronal differentiation in the early chick embryo , 2004, Journal of anatomy.

[57]  B. Halliwell,et al.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? , 2004, British journal of pharmacology.

[58]  Xudong Huang,et al.  Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology , 2004, Annals of the New York Academy of Sciences.

[59]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[60]  R. Pertwee,et al.  (-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens. , 2002, European Journal of Pharmacology.

[61]  O. Devinsky,et al.  Alcohol and Marijuana: Effects on Epilepsy and Use by Patients with Epilepsy , 2001, Epilepsia.

[62]  M. De Felici,et al.  Down-regulation of anandamide hydrolase in mouse uterus by sex hormones. , 2000, European journal of biochemistry.

[63]  J. Joseph,et al.  Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. , 1999, Free radical biology & medicine.

[64]  S. Dey,et al.  Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development. , 1999, Biology of reproduction.

[65]  S. Dey,et al.  Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. , 1998, Biology of reproduction.

[66]  E. Lissi,et al.  Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements. , 1995, Free radical biology & medicine.

[67]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[68]  E. Carlini,et al.  Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man. , 1974, European journal of pharmacology.

[69]  R. Mechoulam,et al.  The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. , 1971, Journal of the American Chemical Society.

[70]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[71]  A. Tatar,et al.  Neuroprotective Effects of Farnesene Against Hydrogen Peroxide-Induced Neurotoxicity In vitro , 2013, Cellular and Molecular Neurobiology.

[72]  J. Maag,et al.  Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro. , 2012, Neurotoxicology.

[73]  A. Makriyannis,et al.  Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells , 2007, PloS one.

[74]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .